HOME >> BIOLOGY >> NEWS
Statins may prevent damage by Alzheimer's disease protein, USF study finds

Tampa, FL (April 2, 2002) Commonly-used cholesterol-lowering drugs, known as statins, block damage by an Alzheimer's-associated protein in neurons and blood vessels, a study by University of South Florida researchers found.

The researchers looked at the biochemical effects of statins in reducing damage from Alzheimer's disease. Their study is published in today's issue of the journal Atherosclerosis.

"Statins block the vasoconstrictive effects of the A-beta protein a critical protein involved in Alzheimer's disease pathology," said Daniel Paris, PhD, first author of the study and an assistant professor at the USF Roskamp Institute. "These drugs appear to have anti-inflammatory properties, independent of their benefit in lowering cholesterol, that may help protect against dementia."

Recently, the risk of developing Alzheimer's disease has been shown to be reduced in populations treated with statins, although the reason is unclear. Other studies indicate that high cholesterol or other cardiovascular conditions also increase the risk for Alzheimer's disease.

The Roskamp researchers, searching for clues to understand the preventive action of statins, were struck by the similar effects of cholesterol and the A-beta protein (A) in blood vessels. Both compounds promote the constriction of blood vessels through a similar mechanism. They hypothesized that the same drugs that inhibit the production of cholesterol might affect A's stimulation of inflammatory substances that result in blood vessel constriction.

The researchers studied the effects of two statins most commonly used to treat high cholesterol mevinolin (lovastatin) and mevastatin (compactin).

A appears to be toxic to human neuronal cells cultured in the laboratory. But, when these same neurons were treated with mevastatin, the neurotoxicity normally induced by A was prevented, the researchers found.

The researchers also looked at the effect of
'"/>

Contact: Anne DeLotto Baier
abaier@hsc.usf.edu
813-974-3300
University of South Florida Health
2-Apr-2002


Page: 1 2

Related biology news :

1. Statins beneficial effects on HDL
2. Leader in cancer treatment and prevention research honored
3. Research suggests new avenue for stopping, preventing colon cancer
4. Viral proteins may prevent bacterial infections
5. OHSU researchers discover possible method for early detection, prevention of premature birth
6. Colleagues to recognize research leadership in cancer detection, prevention and treatment
7. Rutgers cancer prevention expert calls for FDA action to reduce colon cancer and osteoporosis
8. Drug prevents chemotherapy-induced hearing loss, study finds
9. Lack of immune system protein prevents lupus-like condition in mice
10. Combination of gene therapy and gene silencing prevents neurodegenerative disease
11. Antioxidants during pregnancy may help prevent birth defects tied to alcohol

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/21/2020)... ... August 18, 2020 , ... Sentien Biotechnologies, Inc., a ... U.S. Food and Drug Administration (FDA) has approved the company’s Investigational New Drug ... of severe COVID-19. Approval of this IND allows Sentien to initiate a Phase ...
(Date:8/12/2020)... ... August 11, 2020 , ... Both Roche, based ... entered into license agreements with Housey Pharma’s HMI subsidiary to gain access to ... have annual Research and Development spending in excess of US $10 billion. , ...
(Date:8/5/2020)... ... ... Regenative Labs has received approval from the Centers for Medicare & Medicaid ... Wharton’s jelly allografts to be assigned a Q code and be approved for application ... jelly allograft product to be recognized as a 361 HCT/P by CMS regulated under ...
Breaking Biology News(10 mins):
(Date:8/12/2020)... LEXINGTON, Mass. (PRWEB) , ... August 11, 2020 ... ... awarded $300,000 a year to expand the Facioscapulohumeral Muscular Dystrophy Clinical Trial ... year in 2021 and 2022. The network is a consortium of academic research ...
(Date:8/3/2020)... ... August 03, 2020 , ... Introducing Ardent Animal Health ... growth, , Known as MediVet Biologics since its formation in ... The new Ardent Animal Health will build on its base of innovative therapies ...
(Date:7/31/2020)... ... July 29, 2020 , ... ... leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, ... have entered into a strategic partnership whereby Catalent will provide support for the ...
(Date:7/18/2020)... ... July 16, 2020 , ... After research model surgery and catheter implantation, ... surgery is only the beginning of a successful study, while protecting and accessing the ... Gien, Global Head of Surgery from Envigo in a live webinar ...
Breaking Biology Technology:
Cached News: